Rhabdomyolysis from erlotinib: A case report

Tumori

Volumn 97, Issue 3, 2011, Pages 415-416

  Moscetti, Luca ^a   Nelli, Fabrizio ^a   Ruggeri, Enzo Maria ^a  

^a BELCOLLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CREATINE KINASE; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEMCITABINE; MYOGLOBIN;

AGED; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CASE REPORT; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LETTER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; MYALGIA; PATIENT MONITORING; RHABDOMYOLYSIS;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; QUINAZOLINES; RHABDOMYOLYSIS;

EID: 79960889088     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/912.10044     Document Type: Letter

References (7)

1. D'Addario G, Felip E: Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol, 20 (Suppl 4): 68-70, 2009.
2. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, van Kooten M, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santabárbara P, Seymour L; National Cancer Institute of Canada Clinical Trials Group: Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med, 353: 123-132, 2005. (Pubitemid 41058344)
3. Penel N, Blay JY, Adenis A: Imatinib as a possible cause of severe rhabdomyolysis. N Engl J Med, 358: 2746-2747, 2008. (Pubitemid 351860895)
4. Cibeira MT, Mercadal S, Arenillas L, Muntanola A, Salamero O, Blade J: Bortezomib-induced rhabdomyolysis inmultiple myeloma. Acta Haematol, 116: 203-206, 2006.
5. Anderlini P, Buzaid AC, Legha SS: Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer, 76: 678-679, 1995.
6. Khan FY: Rhabdomyolysis: a review of the literature. Neth J Med, 67: 272-283, 2009.
7. Veeraputhiran M, Sundermeyer M: Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin. Clin Lung Cancer, 9: 232-234, 2008.